2-[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridylmethylthio] benzimidazole
Lansoprazole sulfide intermediate controlled for polymorph and sulphide levels to drive efficient sulfoxidation (CAS 103577-40-8). End use: Lansoprazole.
Product overview
Lansoprazole is a proton pump inhibitor used for GERD, peptic ulcers and H. pylori eradication.
Rraynex catalogues 2-[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridylmethylthio] benzimidazole as a lansoprazole intermediate, for use in the lansoprazole synthesis route.
Pharmaceutical intermediates are compounds produced at a defined stage of an API synthesis route and supplied to API manufacturers for the following reaction steps.
Pharmaceutical applications
- Synthesis of lansoprazole API.
- Route development and scale-up by API manufacturers.
Product specifications
- Product
- 2-[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridylmethylthio] benzimidazole
- Form
- Intermediate
- Therapeutic category
- Lansoprazole Intermediate
- CAS number
- 103577-40-8
- Strength
- Agreed per project — share your target strength in the enquiry
- Grade
- Custom / On Request
- Pack size
- 5/25 kg
- Site certifications
- WHO-GMP, ISO 9001, ISO 14001
Detailed specifications, COA and technical documentation are shared on request.
Supply and enquiries
Rraynex supplies 2-[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridylmethylthio] benzimidazole to pharmaceutical manufacturers, formulation developers and CDMOs in 5/25 kg packs with batch traceability. Send your quantity, grade and documentation needs through the enquiry form and the commercial team will reply with specifications and a quotation. Rraynex is a B2B supplier and does not sell to consumers.
Send product enquiry Browse all intermediates Manufacturing capabilities
Other Lansoprazole products from Rraynex
- 2-Chloromethyl-3-methyl-4-(2,2,2-trifluoroethoxy) pyridine HCl — Intermediate
- Lansoprazole — Pellets